IMPACT Therapeutics, Inc (HKG:7630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.07
+0.14 (1.01%)
Sep 30, 2026, 4:08 PM HKT

IMPACT Therapeutics Statistics

Total Valuation

HKG:7630 has a market cap or net worth of HKD 3.93 billion. The enterprise value is 2.71 billion.

Market Cap3.93B
Enterprise Value 2.71B

Important Dates

The next estimated earnings date is Tuesday, December 1, 2026.

Earnings Date Dec 1, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:7630 has 282.46 million shares outstanding.

Current Share Class 282.46M
Shares Outstanding 282.46M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 8.55%
Owned by Institutions (%) 14.67%
Float 117.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 28.83
PB Ratio 4.39
P/TBV Ratio 4.42
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 19.86
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.06, with a Debt / Equity ratio of 0.01.

Current Ratio 8.06
Quick Ratio 7.77
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.04
Interest Coverage -3.72

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -21.85%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 1.55M
Profits Per Employee -3.38M
Employee Count 88
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, HKG:7630 has paid 1,154 in taxes.

Income Tax 1,154
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 13.19
200-Day Moving Average n/a
Relative Strength Index (RSI) 50.85
Average Volume (20 Days) 8,419,996

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:7630 had revenue of HKD 136.46 million and -297.86 million in losses. Loss per share was -1.24.

Revenue136.46M
Gross Profit 124.12M
Operating Income -255.51M
Pretax Income -297.86M
Net Income -297.86M
EBITDA -254.33M
EBIT -255.51M
Loss Per Share -1.24
Full Income Statement

Balance Sheet

The company has 1.23 billion in cash and 4.88 million in debt, with a net cash position of 1.23 billion or 4.34 per share.

Cash & Cash Equivalents 1.23B
Total Debt 4.88M
Net Cash 1.23B
Net Cash Per Share 4.34
Equity (Book Value) 895.61M
Book Value Per Share 3.17
Working Capital 1.16B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -117.38 million and capital expenditures -492,960, giving a free cash flow of -117.87 million.

Operating Cash Flow -117.38M
Capital Expenditures -492,960
Depreciation & Amortization 1.20M
Net Borrowing -3.51M
Free Cash Flow -117.87M
FCF Per Share -0.42
Full Cash Flow Statement

Margins

Gross margin is 90.95%, with operating and profit margins of -187.24% and -218.27%.

Gross Margin 90.95%
Operating Margin -187.24%
Pretax Margin -218.27%
Profit Margin -218.27%
EBITDA Margin -186.37%
EBIT Margin -187.24%
FCF Margin n/a

Dividends & Yields

HKG:7630 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -7.57%
FCF Yield -3.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:7630 has an Altman Z-Score of 13.3 and a Piotroski F-Score of 1.

Altman Z-Score 13.3
Piotroski F-Score 1